Weefsel Pharma - A Forerunning Montelukast Tablets Manufacturer and Exporter in India
While manufacturing and exporting a wide range of core and allied pharmaceutical products to more than fifty nations across the globe, we at Weefsel Pharma have come across with numerous pharma drugs (which includes both branded as well as generic ones), that are seeing hude demand of bulk production from the international market. Montelukast tablets, with its limited usage; are definitely needs a mention in this regard.
Combinations of Montelukast Tablets Manufactured by Weefsel Pharma
- Montelukast Sodium + Levocetirizine HCL
- Montelukast Sodium IP + Levocetirizine HCL IP
Products :
Product/Composition | Strength | View |
---|---|---|
Levosel LM Tablets | 10mg + 5mg | View |
Montelukast and Levocetirizine Tablets | 10mg + 10mg, 10mg + 5mg, 4mg + 2.5mg | View |
Montelukast Tablets | 10mg, 4mg, 5mg | View |
Montelukast and Fexofenadine Tablets | 10mg + 120mg | View |
Levocetirizine and Montelukast Syrup | 2.5mg + 4mg | View |
What is a Montelukast Tablet?
Montelukast happens to be a medication used in the treatment of asthma, although it has lesser popularity compared to the inhaled corticosteroids; as it is not useful for acute asthma attacks.
Some other cases where this drug can be used include long-term hives and allergic rhinitis; for which it is a second-line treatment.
Montelukast is usually taken in the dosage form of a tablet, chewable tablet, or as granules.
How do Montelukast Tablets work?
In simplest of terms, Montelukast works by blocking the action of leukotriene D4 in the lungs resulting in decreased inflammation and relaxation of smooth muscle.
Montelukast acts as a leukotriene receptor antagonist (cysteinyl leukotriene receptors) and eventually shuts the function of these inflammatory mediators. Leukotrienes are produced by the immune system and serve to promote bronchoconstriction, inflammation, microvascular permeability, and mucus secretion in cases of asthma and COPD.
While technically speaking, it is a leukotriene receptor antagonist that binds with strong association and selectivity to the CysLT type 1 receptor, which again helps in inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may facilitate asthma or allergic rhinitis.
When to avoid taking Montelukast Tablets?
- Mental illness or psychosis
- Asthma
- A history of severe allergic reaction to aspirin or NSAID
- Pregnant
- Breastfeeding woman
- Phenylketonuria (PKU)
Popular Diseases or Health Issues treated by Montelukast Tablets
- Asthma
- Exercise-Induced Bronchospasm
- Perennial Allergic Rhinitis (PAR)
- Seasonal Allergic Rhinitis
- Hives
- Allergic reactions during the administration of intravenous immunoglobulin
- Symptomatic treatment of mastocytosis
Popular Brand Names of Montelukast Tablets
- Singulair
Substitutes of Montelukast Tablets
- Alcohol
- Aromatic alcohol
- Aromatic heteropolycyclic compound
- Aryl chloride
- Aryl halide
- Azacycle
- Benzenoid
- Carbonyl group
- Carboxylic acid
- Carboxylic acid derivative
- Chloroquinoline
- Dialkylthioether
- Fatty acyl
- Haloquinoline
- Heteroaromatic compound
- Hydrocarbon derivative
- Hydroxy fatty acid
- Linear 1,3-diarylpropanoid
- Monocarboxylic acid or derivatives
- Monocyclic benzene moiety
- Organic nitrogen compound
- Organic oxide
- Organic oxygen compound
- Organochloride
- Organohalogen compound
- Organoheterocyclic compound
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Organosulfur compound
- Phenylpropane
- Pyridine
- Quinoline
- Styrene
- Sulfenyl compound
- Tertiary alcohol
- Thia fatty acid
- Thioether